INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.
(Q48428683)
scientific article published on 5 September 2006
scientific article published on 5 September 2006
Language: